AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org
Episodes
8 episodes
Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Cindy Carlsson , Professor of Medicine Geriatrics at the University of Wisconsin School of Medicine and Public Health and staff physician at t...
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duk...
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of...
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Loli...
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San F...
Pathology and Diagnostic Frameworks for Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-...
Evaluation of Cognition and Cognitive Disorder
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Dire...
Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Dis...